March Altus Capital Management as of June 30, 2016
Portfolio Holdings for March Altus Capital Management
March Altus Capital Management holds 8 positions in its portfolio as reported in the June 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| ACADIA Pharmaceuticals (ACAD) | 20.8 | $2.7M | 83k | 32.46 | |
| Eli Lilly & Co. (LLY) | 16.3 | $2.1M | 27k | 78.74 | |
| Edwards Lifesciences (EW) | 14.3 | $1.9M | 19k | 99.73 | |
| Johnson & Johnson (JNJ) | 12.2 | $1.6M | 13k | 121.31 | |
| Align Technology (ALGN) | 10.8 | $1.4M | 17k | 80.55 | |
| Aratana Therapeutics | 10.7 | $1.4M | 219k | 6.32 | |
| Alexion Pharmaceuticals | 7.8 | $1.0M | 8.6k | 116.76 | |
| Dex (DXCM) | 7.2 | $928k | 12k | 79.32 |
